🎉 Finosauras is now  SarasRead more
Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd - Share Price Target 2026

(NSE: BLISSGVS)

Sector: Healthcare

Market Cap: 1661.42 Cr

184.51

-

227.49

Target Price Range

162.76

+8.07 (4.96%)

CMP

Bullish

As on 23 Jan 2026, 01:30 pm

Market Trends

Based on 6 technical indicators.
Bullish3
Bearish1
Neutral2
Agg. Profit Potential26.49%
Agg. Risk 26.32%

Last updated on: 23/01/2026, 1:30 pm

Returns

PeriodReturn %
1 Month8.51
3 Months5.16
1 Year-2.20
5 Years-17.99

Last updated on: 09/01/2026, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
ARIAN INVESTMENT LIMITED7.43%7,853,888
LIFE INSURANCE CORPORATION OF INDIA5.98%6,313,598
COEUS GLOBAL OPPORTUNITIES FUND1.76%1,859,594
ARK GLOBAL EMERGING COMPANIES, LP1.71%1,806,267

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

21.21

P/B Ratio

1.51

PEG Ratio

0.51

ROE

6.78%

EPS

7.41

Dividend Yield

0.32%

Market Cap

1661.42 Cr

Sector

N/A

Last Updated: 21 Jan 2026, 02:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Bliss GVS Pharma Ltd.

Incorporated Year

1984

City and State

Mumbai, Maharashtra

Listing Date

Director's Name

Vibha Gagan Sharma

Revenue

667.20 Cr

Net Profit

68.97 Cr